View : 903 Download: 0

Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial

Title
Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial
Authors
Kwak, Jae-Yong; Kim, Hawk; Kim, Jeong A.; Do, Young Rok; Kim, Hyeoung Joon; Park, Joon Seong; Chung, Joo Seop; Shin, Ho-Jin; Kim, Sung-Hyun; Kim, Dae-Young; Bunworasate, Udomsak; Choi, Chul Won; Comia, Narcisa Sonia Cornejo; Zang, Dae Young; Oh, Sukjoong; Jootar, Saengsuree; Reksodiputro, Ary Harryanto; Lee, Won Sik; Mun, Yeung-Chul; Kong, Jee Hyun; Caguioa, Priscilla B.; Park, Jinny; Jung, Chul Won; Kim, Dong-Wook
Ewha Authors
문영철
SCOPUS Author ID
문영철scopus
Issue Date
2015
Journal Title
BLOOD
ISSN
0006-4971JCR Link

1528-0020JCR Link
Citation
BLOOD vol. 126, no. 23
Publisher
AMER SOC HEMATOLOGY
Indexed
SCI; SCIE; SCOPUS WOS
Document Type
Meeting Abstract
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE